Don't confuse bargain shopping with saving lives!

FIGHT COLORECTAL CANCER RESPONSE TO NEW YORK TIMES ARTICLE (6/03/2013): Fight Colorectal Cancer applauds the New York Times for shedding light on how revenue is generated by medical practices. Importantly however, the crux of the issue is not the use or overuse of colonoscopies and the variance in pricing. Rather, the main problem to be fixed…  Read More

New organization works to insure the uninsured

Under the new health care law, millions of Americans will benefit from more accessible and affordable health care – but the key will be getting individuals actually enrolled. Enroll America is a new nonpartisan, nonprofit organization whose mission is to ensure that all Americans are enrolled in and retain health coverage. It will work at the…  Read More

Cost of Cancer Care Expected to Skyrocket in Next Decade

The U.S. sticker price for cancer care by 2020 will likely increase at least 27% over the next decade, to a minimum $158 billion yearly by 2020, according to the National Cancer Institute. Colorectal cancer ranks 2nd behind breast cancer in 2010 total costs of care by cancer type, and will remain one of the top…  Read More

Colon Cancer Screening Saves More Money

With the increasing expense of treating colorectal cancer, treatment cost savings in the near future will more than double when screening prevents colon and rectal cancers or finds them early. Looking at expense for an entire population, all screening methods except colonoscopy cost less than treating those cancers that developed, and the net cost of colonoscopy screening…  Read More

This Week's Colorectal Cancer News in Brief: January 30

This week’s reports include information about mismatch repair genes in stage IV colorectal cancer, colon surgery complications for very obese patients, and the impact of computerization on hospital outcomes. In addition, there are links to the Surgeon General’s new Family Health Portrait and a report from Families USA on health care insurance costs for laid off…  Read More

KRAS Testing Has Potential to Save Millions in Health Care Costs

Update from the 2009 Gastrointestinal Cancer Symposium Over half a billion dollars could potentially be saved if all patients with colorectal cancer that had spread were tested for the KRAS gene before beginning treatment. Because patients with mutated KRAS in their tumors don’t benefit from treatment with EGFR inhibitors Erbitux® (cetuximab) and Vectibix™ (panitumumab), offering them…  Read More